CL2004000636A1 - Procedimiento de preparacion de ciclesonida en forma cristalina, con un tamano definido de particulas; ciclesonida cristalina; composicion farmaceutica que contiene dicho compuesto, util como antiinflamatorio. - Google Patents

Procedimiento de preparacion de ciclesonida en forma cristalina, con un tamano definido de particulas; ciclesonida cristalina; composicion farmaceutica que contiene dicho compuesto, util como antiinflamatorio.

Info

Publication number
CL2004000636A1
CL2004000636A1 CL200400636A CL2004000636A CL2004000636A1 CL 2004000636 A1 CL2004000636 A1 CL 2004000636A1 CL 200400636 A CL200400636 A CL 200400636A CL 2004000636 A CL2004000636 A CL 2004000636A CL 2004000636 A1 CL2004000636 A1 CL 2004000636A1
Authority
CL
Chile
Prior art keywords
cyclesonide
crystalline
preparation
particles
antiinflamatory
Prior art date
Application number
CL200400636A
Other languages
English (en)
Inventor
Beate Kaupp Stefan Stu Schmidt
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000636(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of CL2004000636A1 publication Critical patent/CL2004000636A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL INVENTO SE REFIERE A UN NUEVO PROCEDIMIENTO PARA LA PREPARACION DE CICLESONIDA CRISTALINA CON UN TAMANO VENTAJOSO DE PARTICULAS Y A LA UTILIZACION PARA LA PREPARACION DE FORMULACIONES FARMACEUTICAS, EN PARTICULAR PARA LA APLICACION POR VIA TOPICA. LA CICLESONIDA CRISTALINA OBTENIDA DE ACUERDO CO EL NUEVO PROCEDIMIENTO PRESENTA VENTAJOSAS PROPIEDADES AERODINAMICAS , Y SE PUEDE TRANSFORMAR ULTERIORMENTE, SIN NINGUNA MICRONIZACION ADICIONAL POR MEDIOS MECANICOS, EN FORMULACIONES FARMACEUTICAS INHALABLES O QUE SE ADMINISTRAN POR VIA NASAL.
CL200400636A 2003-03-27 2004-03-25 Procedimiento de preparacion de ciclesonida en forma cristalina, con un tamano definido de particulas; ciclesonida cristalina; composicion farmaceutica que contiene dicho compuesto, util como antiinflamatorio. CL2004000636A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03007007 2003-03-27
DE10314097 2003-03-27

Publications (1)

Publication Number Publication Date
CL2004000636A1 true CL2004000636A1 (es) 2005-02-04

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400636A CL2004000636A1 (es) 2003-03-27 2004-03-25 Procedimiento de preparacion de ciclesonida en forma cristalina, con un tamano definido de particulas; ciclesonida cristalina; composicion farmaceutica que contiene dicho compuesto, util como antiinflamatorio.

Country Status (27)

Country Link
US (1) US9422327B2 (es)
EP (1) EP1611150B1 (es)
JP (1) JP4746535B2 (es)
KR (1) KR101102709B1 (es)
AR (1) AR043579A1 (es)
AT (1) ATE546459T1 (es)
AU (1) AU2004224092B2 (es)
BR (1) BRPI0408569B1 (es)
CA (1) CA2519752C (es)
CL (1) CL2004000636A1 (es)
CY (1) CY1112970T1 (es)
DK (1) DK1611150T3 (es)
EA (1) EA011157B1 (es)
ES (1) ES2382928T3 (es)
HR (1) HRP20050917B1 (es)
IL (1) IL170746A (es)
MX (1) MXPA05010041A (es)
MY (1) MY143936A (es)
NO (1) NO331984B1 (es)
NZ (1) NZ542827A (es)
PE (1) PE20050388A1 (es)
PL (1) PL1611150T3 (es)
PT (1) PT1611150E (es)
RS (1) RS52549B (es)
SI (1) SI1611150T1 (es)
TW (1) TWI328589B (es)
WO (1) WO2004085460A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1869064A2 (en) * 2005-11-02 2007-12-26 Sicor, Inc. Improved process for the preparation of ciclesonide
JP2009526068A (ja) * 2006-02-08 2009-07-16 シコール インコーポレイティド シクレソニド結晶形
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
KR20090078329A (ko) * 2006-09-19 2009-07-17 씨아이피엘에이 엘티디. 시클레소니드의 제조방법 및 그의 결정형
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
MX2010009303A (es) * 2008-03-13 2010-12-02 Farmabios Spa Proceso para la preparacion de derivados de pregnano.
US20100120733A1 (en) * 2008-11-07 2010-05-13 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007770A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
MY194619A (en) 2016-06-02 2022-12-07 Abbvie Inc Glucocorticoid receptor agonist and immunoconjugates thereof
AU2018374634A1 (en) 2017-12-01 2020-05-28 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
HU209603B (en) 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
UA45311C2 (uk) * 1993-04-02 2002-04-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх 16<font face="Symbol">a</font>,17-ЦИКЛОГЕКСИЛМЕТИЛЕНДІОКСИ-11<font face="Symbol">b</font>,21-ДИГІДРОКСИПРЕГНА-1,4-ДІЄН-3,20-ДІОН, СПОСІБ ЙОГО ОДЕРЖАННЯ, ЛІКАРСЬКИЙ ЗАСІБ
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
DK0749438T3 (da) * 1994-03-09 2001-04-02 Byk Gulden Lomberg Chem Fab Hidtil ukendte silylforbindelser og deres anvendelse
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
JP4570251B2 (ja) * 1998-07-24 2010-10-27 ヤゴテック アーゲー 医薬用エーロゾル製剤
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
AU5405200A (en) 1999-06-25 2001-01-31 Cognis Deutschland Gmbh & Co. Kg Use of nanoscale sterols and sterol esters
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
MXPA03004123A (es) 2000-11-10 2004-09-10 Altan Pharma Kg Proceso para la produccion de 16, 17-[(ciclohexilmetilen) bis(oxy)]-11, 21-dihidroxi-pregna-1, 4-dien-3, 20-dion o su 21-isobutirat por trnasquetalisacion.

Also Published As

Publication number Publication date
EP1611150B1 (en) 2012-02-22
PL1611150T3 (pl) 2012-07-31
JP2006521332A (ja) 2006-09-21
MY143936A (en) 2011-07-29
BRPI0408569A (pt) 2006-03-21
PT1611150E (pt) 2012-05-07
IL170746A0 (en) 2009-02-11
WO2004085460A1 (en) 2004-10-07
RS52549B (sr) 2013-04-30
BRPI0408569B1 (pt) 2017-08-29
TW200418519A (en) 2004-10-01
HRP20050917A2 (en) 2006-12-31
SI1611150T1 (sl) 2012-06-29
EP1611150A1 (en) 2006-01-04
US9422327B2 (en) 2016-08-23
DK1611150T3 (da) 2012-05-14
CY1112970T1 (el) 2016-04-13
CA2519752A1 (en) 2004-10-07
EA200501391A1 (ru) 2006-06-30
HRP20050917B1 (hr) 2014-02-14
ES2382928T3 (es) 2012-06-14
AU2004224092A1 (en) 2004-10-07
NO331984B1 (no) 2012-05-21
NZ542827A (en) 2008-02-29
KR20050114250A (ko) 2005-12-05
ATE546459T1 (de) 2012-03-15
CA2519752C (en) 2012-05-29
TWI328589B (en) 2010-08-11
NO20054835L (no) 2005-10-19
AU2004224092B2 (en) 2010-03-04
US20060128954A1 (en) 2006-06-15
AR043579A1 (es) 2005-08-03
HK1088905A1 (zh) 2006-11-17
MXPA05010041A (es) 2005-11-17
IL170746A (en) 2012-06-28
KR101102709B1 (ko) 2012-01-05
RS20050704A (sr) 2007-06-04
EA011157B1 (ru) 2009-02-27
WO2004085460A8 (en) 2007-03-15
PE20050388A1 (es) 2005-05-30
JP4746535B2 (ja) 2011-08-10

Similar Documents

Publication Publication Date Title
CL2004000636A1 (es) Procedimiento de preparacion de ciclesonida en forma cristalina, con un tamano definido de particulas; ciclesonida cristalina; composicion farmaceutica que contiene dicho compuesto, util como antiinflamatorio.
WO2008008364A3 (en) Enhanced stability phenylephrine liquid compositions
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
WO2009086400A3 (en) Recombinant vwf formulations
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
MX2009010289A (es) Composiciones para administracion nasal.
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina&#34;
IL198687A0 (en) Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
CY1118496T1 (el) Φαρμακεyτικες συνθεσεις
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
EA201290789A1 (ru) Термогелеобразующие композиции анестетиков
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
SV2008003088A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
UA105914C2 (uk) Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
NZ709958A (en) Enhanced stability of novel liquid compositions
UY32187A (es) Composiciones farmaceuticas topicas
WO2009031318A1 (ja) 鎮痛・抗炎症剤含有外用剤
MX2011010547A (es) Composiciones farmaceuticas estables de diclofenaco.
SG152257A1 (en) Topical preparation containing ambroxol
TN2009000358A1 (en) Pharmaceutical compositions comprising a calcilytic agent
CL2013002353A1 (es) Uso de una composicion farmaceutica que contiene al menos un compuesto que contiene selenita y al menos un acido farmaceuticamente aceptable, util en la preparacion de un medicamento para el tratamiento de alteraciones celulares cervicales que tienen una calificacion pap de pap iii o pap iiid y/o una calificacion cin &gt; o = a cin 1.
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
WO2008062274A3 (en) Pharmaceutical formulations of nsaids for parentral use